Literature DB >> 7198119

Prostate alpha-protein. Isolation and characterization of the polypeptide components and cholesterol binding.

C Chen, K Schilling, R A Hiipakka, I Y Huang, S Liao.   

Abstract

alpha-Protein, a major glycoprotein in the cytosol fraction of rat ventral prostate, has a molecular weight of about 50,000 and can be dissociated, by sodium dodecyl sulfate, into two different subunits (A and B). alpha-Protein has three different polypeptide components with apparent molecular weights of 10,000 (I), 14,000 (II), and 15,000 (III). These components were purified to homogeneity and their amino acid compositions were determined. Subunit A is composed of Components I and III, whereas subunit B is composed of Components II and III. Carbohydrate was detectable only on Component III. Component III isolated from subunit A and Component III isolated from subunit B appear to be identical. The purified alpha-protein contains 0.7-1 mol of cholesterol/mol of protein. If cholesterol was removed by acetone, about 1 mol of 5 alpha-dihydrotestosterone or pregnenolone could bind to 1 mol of alpha-protein. In the presence of 2 mM ZnCl2, alpha-protein can form dimers and tetramers. In cell-free systems, alpha-protein can inhibit binding of the androgen-receptor complex to nuclear chromatin and also can promote the release of the complex already bound to chromatin. This effect is due to polypeptide Component I.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7198119

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

1.  Intracellular inactivation, reactivation and dynamic status of prostate androgen receptors.

Authors:  G P Rossini; S Liao
Journal:  Biochem J       Date:  1982-11-15       Impact factor: 3.857

2.  Estramustine-binding protein in malignant glioma in rat.

Authors:  A E Karlsson; P Björk; A T Bergenheim; J Sandström; H Hedman; R Henriksson
Journal:  J Neurooncol       Date:  2000-08       Impact factor: 4.130

Review 3.  Pharmacokinetics and pharmacodynamics of estramustine phosphate.

Authors:  A T Bergenheim; R Henriksson
Journal:  Clin Pharmacokinet       Date:  1998-02       Impact factor: 6.447

4.  Immunochemical characterization of the androgen-dependent spermine-binding protein of the rat ventral prostate.

Authors:  R A Hiipakka; C Chen; K Schilling; A Oberhauser; A Saltzman; S Liao
Journal:  Biochem J       Date:  1984-03-01       Impact factor: 3.857

5.  Purification and biochemical characterization of three major acidic proteins (BSP-A1, BSP-A2 and BSP-A3) from bovine seminal plasma.

Authors:  P Manjunath; M R Sairam
Journal:  Biochem J       Date:  1987-02-01       Impact factor: 3.857

6.  Androgen regulation of prostatic binding protein messenger RNA studied by using cloned complementary DNA.

Authors:  O D Mpanias; S T Hiremath; T Y Wang
Journal:  Mol Cell Biochem       Date:  1983       Impact factor: 3.396

7.  Autoimmune anti-androgen-receptor antibodies in human serum.

Authors:  S Liao; D Witte
Journal:  Proc Natl Acad Sci U S A       Date:  1985-12       Impact factor: 11.205

8.  Multiple gene action determining a mouse salivary protein phenotype: identification of the structural gene for androgen binding protein (Abp).

Authors:  S R Dlouhy; R C Karn
Journal:  Biochem Genet       Date:  1984-08       Impact factor: 1.890

9.  Prostatein (or rat prostatic steroid binding protein) is a major autoantigen in experimental autoimmune prostatitis.

Authors:  M Maccioni; V E Rivero; C M Riera
Journal:  Clin Exp Immunol       Date:  1998-05       Impact factor: 4.330

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.